OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S
Click here to access the webcast of 29 July 2011
For more information, please direct your request to: Ms. Rianne Roukema, Manager Communications & Investor Relations Email IR@octoplus.nl Telephone +31-71-5244044.
